SavedAdd your journal

Journals / Klinik Psikofarmakoloji Bülteni / 2016 / Cilt: 26 - Sayı: 2

Hyperprolactinemia is a Major Problem in Patients Treated with Antipsychotic Drugs

Ferhat DENİZ
Kamil BASKOY
Seyid Ahmet AY
Arif YONEM
Pages
210–210
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

DENİZ, F., BASKOY, K., AY, S. A., YONEM, A. (2022). Hyperprolactinemia is a Major Problem in Patients Treated with Antipsychotic Drugs. Klinik Psikofarmakoloji Bülteni, Cilt: 26 - Sayı: 2, 210–210. https://ajindex.com/articles/573921

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Ates MA, Tutuncu R, Oner I, Ercan S, Basoglu C, Algul A, et al. Relationship between plasma levels of prolactin and the severity of negative symptoms in patients with schizophrenia. Klinik Psikofarmakoloji Bulteni-Bulletin of Clinical Psychopharmacology 2015;25(1):27-37. [CrossRef] 2. Dilbaz N, Guz H, Arikazan M. Serum gonadal sex hormones early-onset and adult onset schizophrenics: a controlled study. Klinik Psikofarmakoloji Bulteni-Bulletin of Clinical Psychopharmacology 1998;8(2):94-9. (Turkish) 3. Melmed S, Kleinberg K, Ho K. Pituitary Physiology and Diagnostic Evaluation. In: Melmed S, Polonsky KS, (editors). Williams textbook of endocrinology. Philadelphia, PA: Elsevier Saunders; 2011. p. 184-186. [CrossRef] 4. Shimatsu A, Hattori N. Macroprolactinemia: diagnostic, clinical, and pathogenic significance. Clin Dev Immunol 2012;2012:167132. [CrossRef] 5. Molitch ME. Medication-induced hyperprolactinemia. Mayo Clin Proc 2005;80(8):1050-7. [CrossRef]